Citadel Advisors
ACGN

Citadel Advisors’s Aceragen Inc ACGN Stock Holding History

Citadel Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,584
Closed -$28K – 15130
2021
Q3 		$28K Sell
1,584
-553
-26% -$9.97K ﹤0.01% 13590
2021
Q2 		$44K Sell
2,137
-7,714
-78% -$155K ﹤0.01% 13384
2021
Q1 		$217K Buy
+9,851
New +$738K ﹤0.01% 11541
2018
Q1 		– Sell
-12
Closed -$28K – 8949
2017
Q4 		$28K Buy
+12
New +$27.4K ﹤0.01% 7776
2017
Q2 		– Sell
-13
Closed -$36K – 8238
2017
Q1 		$36K Buy
+13
New +$25.1K ﹤0.01% 7121
2016
Q1 		– Sell
-13
Closed -$43K – 8263
2015
Q4 		$43K Buy
13
+2
+18% +$7.16K ﹤0.01% 7430
2015
Q3 		$39K Sell
11
-13
-54% -$46K ﹤0.01% 7755
2015
Q2 		$96K Buy
24
+15
+167% +$55.1K ﹤0.01% 7118
2015
Q1 		$37K Buy
+9
New +$43.9K ﹤0.01% 7578
2014
Q4 		– Sell
-14
Closed -$44.9K – 8426
2014
Q3 		$34K Sell
14
-9
-39% -$25.9K ﹤0.01% 7141
2014
Q2 		$73K Sell
23
-33
-59% -$109K ﹤0.01% 6473
2014
Q1 		$247K Buy
+56
New +$307K ﹤0.01% 5269

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Citadel Advisors's ACGN Position: Q1 2023 in Review

Citadel Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,960 shares — an estimated $17.6K sold.

Citadel Advisors first reported a position in ACGN in Q1 2014 and held it in 26 quarters. The position peaked at $673K in Q1 2014. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

  • Citadel Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 2,960 Aceragen Inc shares in Q1 2023, an estimated $17.6K.
  • Citadel Advisors first reported a position in Aceragen Inc in Q1 2014 and held it in 26 quarters.
  • Citadel Advisors's Aceragen Inc position peaked at $673K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.